Clinical Trial Update: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating litifilimab (BIIB059) for systemic lupus erythematosus, focusing on safety and potential symptom improvement in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Litifilimab (litifilimab)

Snippet

Sponsor: Biogen | Conditions: Lupus Erythematosus, Systemic | Phase 3 | Status: ACTIVE_NOT_RECRUITING